Trial Profile
Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Palmoplantar keratoderma
- Focus Pharmacokinetics
- Sponsors TransDerm
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jun 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.